Role of FDG PET, Immune and Hypoxic Marker in NSCLC

Istituto Clinico Humanitas

Status

Completed

Conditions

Carcinoma, Non-Small-Cell Lung

Treatments

Other: No intervention

Study type

Observational

Funder types

Other

Identifiers

NCT02519062

1332

Details and patient eligibility

About

This is a retrospective study that involves the revision of clinical, instrumental and pathologic data of an estimated cohort of maximum 130 patients with NSCLC treated with surgery with radical intent at our center.

Full description

This is a retrospective observation that involves the revision of clinical, instrumental and pathologic data of an estimated cohort of 130 patients with NSCLC treated with surgery with radical intent at our center.

We will review FDG-PET acquired within 30 days prior to surgery and analyze its principal imaging characteristics with respect to hypoxic and immune-related markers at immunohistochemistry (IHC). These markers will be studied on tumor tissue obtained at surgery, used for diagnostic purposes and stored in paraffin.

Enrollment

130 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria